Literature DB >> 22542659

Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings.

Timothy J Searl1, Eugene M Silinsky.   

Abstract

A study was made to determine if constitutively active adenosine receptors are present at mouse motor nerve endings. In preparations blocked by low Ca(2+)/high Mg(2+) solution, 8-cyclopentyl-1,3,dipropylxanthine (CPX, 10-100 nM), which has been reported to be both an A(1) adenosine receptor antagonist and inverse agonist, produced a dose-dependent increase in the number of acetylcholine quanta released by a nerve impulse. Adenosine deaminase, which degrades ambient adenosine into its inactive congener, inosine, failed to alter the response to 100 nM CPX. 8-Cyclopentyltheophylline (CPT, 3 μM), a competitive inhibitor at A(1) adenosine receptors, prevented the increase in acetylcholine release produced by CPX. At normal levels of acetylcholine release, neither adenosine deaminase nor CPX affected acetylcholine release at low frequencies of nerve stimulation in (+)-tubocurarine blocked preparations. The results suggest that a proportion of the acetylcholine release process is controlled by constitutively active adenosine receptors at murine motor nerve endings, providing the first evidence for constitutive activity of G-protein-coupled receptors that modulate the function of mammalian nerve endings.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542659      PMCID: PMC3358409          DOI: 10.1016/j.ejphar.2012.04.008

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  Modulation of calcium currents is eliminated after cleavage of a strategic component of the mammalian secretory apparatus.

Authors:  Eugene M Silinsky
Journal:  J Physiol       Date:  2005-06-16       Impact factor: 5.182

2.  Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells.

Authors:  J C Shryock; M J Ozeck; L Belardinelli
Journal:  Mol Pharmacol       Date:  1998-05       Impact factor: 4.436

Review 3.  G proteins: transducers of receptor-generated signals.

Authors:  A G Gilman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation.

Authors:  O Nagano; F F Földes; H Nakatsuka; D Reich; Y Ohta; B Sperlagh; E S Vizi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

5.  Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists.

Authors:  H Ma; R D Green
Journal:  Mol Pharmacol       Date:  1992-11       Impact factor: 4.436

6.  A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors.

Authors:  R S Redman; E M Silinsky
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

7.  Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.

Authors:  Eugene M Silinsky
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

8.  Autoreceptor-mediated purinergic and cholinergic inhibition of motor nerve terminal calcium currents in the rat.

Authors:  B R Hamilton; D O Smith
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

9.  ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.

Authors:  R S Redman; E M Silinsky
Journal:  J Physiol       Date:  1994-05-15       Impact factor: 5.182

10.  Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog.

Authors:  E M Silinsky; R S Redman
Journal:  J Physiol       Date:  1996-05-01       Impact factor: 5.182

View more
  3 in total

1.  PQ-69, a novel and selective adenosine A1 receptor antagonist with inverse agonist activity.

Authors:  Min Lu; Bo Wang; Cheng Zhang; Xiaomei Zhuang; Mei Yuan; Haoshan Wang; Weizhang Li; Ruibin Su; Jin Li
Journal:  Purinergic Signal       Date:  2014-09-24       Impact factor: 3.765

2.  A1 Adenosine Receptor-Mediated Inhibition of Parasympathetic Neuromuscular Transmission in Human and Murine Urinary Bladder.

Authors:  Timothy J Searl; Danuta I Dynda; Shaheen R Alanee; Ahmed M El-Zawahry; Kevin T McVary; Eugene M Silinsky
Journal:  J Pharmacol Exp Ther       Date:  2015-11-03       Impact factor: 4.030

3.  Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.

Authors:  Bruno Bragança; Nádia Oliveira-Monteiro; Fátima Ferreirinha; Pedro A Lima; Miguel Faria; Ana P Fontes-Sousa; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2016-03-07       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.